1. Home
  2. AWX vs ENSC Comparison

AWX vs ENSC Comparison

Compare AWX & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWX

Avalon Holdings Corporation

N/A

Current Price

$2.82

Market Cap

9.9M

Sector

Utilities

ML Signal

N/A

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.41

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AWX
ENSC
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
8.2M
IPO Year
1998
2017

Fundamental Metrics

Financial Performance
Metric
AWX
ENSC
Price
$2.82
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $4.08
AVG Volume (30 Days)
9.9K
★ 278.3K
Earning Date
11-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.24
EPS
★ N/A
N/A
Revenue
★ $53,090,000.00
$5,066,650.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.14
N/A
52 Week Low
$2.43
$0.23
52 Week High
$2.93
$2.16

Technical Indicators

Market Signals
Indicator
AWX
ENSC
Relative Strength Index (RSI) 62.45 49.44
Support Level $2.49 $0.39
Resistance Level $2.89 $0.44
Average True Range (ATR) 0.10 0.04
MACD 0.03 -0.00
Stochastic Oscillator 83.75 66.38

Price Performance

Historical Comparison
AWX
ENSC

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment, which is the key revenue driver, provides hazardous and non-hazardous brokerage and management services to industrial, commercial, municipal, and governmental customers, captive landfill management for an industrial customer, and saltwater injection well operations. Its Golf and related operations segment consists of four golf courses and associated clubhouses, which provide dining and banquet facilities, a hotel which provides lodging and resort-related amenities.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: